Back to GetFilings.com



 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

(Mark One)

 

ý  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended July 31, 2002

 

OR

 

o  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to              .

 

Commission File Number 1-5725

 

 

QUANEX CORPORATION

(Exact name of registrant as specified in its charter)

 

 

DELAWARE

 

38-1872178

(State or other jurisdiction of

 

(I.R.S. Employer

incorporation or organization)

 

Identification No.)

 

1900 West Loop South, Suite 1500, Houston, Texas  77027

(Address of principal executive offices and zip code)

 

 

Registrant’s telephone number, including area code:  (713) 961-4600

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  ý  No  o

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Class

 

Outstanding at July 31, 2002

Common Stock, par value $0.50 per share

 

16,354,614

 

 



 

QUANEX CORPORATION

INDEX

 

Part I.

Financial Information:

 

 

 

 

Item 1:

Financial Statements

 

 

 

 

 

Consolidated Balance Sheets — July 31, 2002 and October 31, 2001

 

 

 

 

 

Consolidated Statements of Income — Three and Nine Months Ended July 31, 2002 and 2001

 

 

 

 

 

Consolidated Statements of Cash Flow — Nine Months Ended July 31, 2002 and 2001

 

 

 

 

 

Notes to Consolidated Financial Statements

 

 

 

 

Item 2:

Management’s Discussion and Analysis of Results of Operations and Financial Condition

 

 

 

 

Item 3:

Quantitative and Qualitative Disclosure about Market Risk

 

 

 

 

Part II.

Other Information

 

 

 

 

Item 5:

Other Information

 

 

 

 

Item 6:

Exhibits and Reports on Form 8-K

 

 



 

PART I. FINANCIAL INFORMATION

 

 

Item 1. Financial Statements

 

QUANEX CORPORATION

CONSOLIDATED BALANCE SHEETS

(In thousands)

(Unaudited)

 

 

 

July 31,
2002

 

October 31,
2001

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and equivalents

 

$

1,340

 

$

29,573

 

Accounts and notes receivable, net

 

110,684

 

109,706

 

Other receivables

 

26,041

 

 

Inventories

 

93,229

 

83,109

 

Deferred income taxes

 

11,783

 

10,907

 

Other current assets

 

3,461

 

3,583

 

Total current assets

 

246,538

 

236,878

 

 

 

 

 

 

 

Property, plant and equipment

 

769,764

 

736,952

 

Less accumulated depreciation and amortization

 

(413,010

)

(379,317

)

Property, plant and equipment, net

 

356,754

 

357,635

 

 

 

 

 

 

 

Goodwill, net

 

66,436

 

59,226

 

Intangible assets

 

2,899

 

 

Other assets

 

27,970

 

43,892

 

 

 

 

 

 

 

 

 

$

700,597

 

$

697,631

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

81,123

 

$

76,831

 

Accrued expenses

 

51,931

 

50,659

 

Income taxes payable

 

3,544

 

1,087

 

Other current liabilities

 

4,945

 

5,593

 

Current maturities of long-term debt

 

81,434

 

420

 

Total current liabilities

 

222,977

 

134,590

 

 

 

 

 

 

 

Long-term debt

 

10,203

 

219,608

 

Deferred pension credits

 

6,281

 

7,962

 

Deferred postretirement welfare benefits

 

7,848

 

7,777

 

Deferred income taxes

 

32,595

 

29,282

 

Other liabilities

 

15,820

 

18,435

 

Total liabilities

 

295,724

 

417,654

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock, no par value

 

 

 

Common stock, $.50 par value

 

8,198

 

7,043

 

Additional paid-in capital

 

182,742

 

108,314

 

Retained earnings

 

219,646

 

186,274

 

Unearned compensation

 

(533

)

(897

)

Accumulated other comprehensive income

 

(4,226

)

(7,212

)

 

 

405,827

 

293,522

 

Less:  Common stock held by rabbi trust

 

(954

)

(873

)

Less:  Cost of shares of common stock in treasury

 

 

(12,672

)

Total stockholders’ equity

 

404,873

 

279,977

 

 

 

 

 

 

 

 

 

$

700,597

 

$

697,631

 

 

1



 

QUANEX CORPORATION

CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per share amounts)

(Unaudited)

 

 

 

Three Months Ended
July 31,

 

Nine Months Ended
July 31,

 

 

 

2002

 

2001

 

2002

 

2001

 

Net sales

 

$

266,891

 

$

248,121

 

$

720,634

 

$

668,320

 

Cost and expenses:

 

 

 

 

 

 

 

 

 

Cost of sales

 

216,469

 

205,581

 

591,882

 

560,625

 

Selling, general and administrative expense

 

14,099

 

13,492

 

39,960

 

38,188

 

Depreciation and amortization

 

11,292

 

10,695

 

33,884